These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 15158948)

  • 1. Acetaminophen-containing chewable tablets with suppressed bitterness and improved oral feeling.
    Suzuki H; Onishi H; Hisamatsu S; Masuda K; Takahashi Y; Iwata M; Machida Y
    Int J Pharm; 2004 Jun; 278(1):51-61. PubMed ID: 15158948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of oral acetaminophen chewable tablets with inhibited bitter taste.
    Suzuki H; Onishi H; Takahashi Y; Iwata M; Machida Y
    Int J Pharm; 2003 Jan; 251(1-2):123-32. PubMed ID: 12527182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
    Cao QR; Choi YW; Cui JH; Lee BJ
    J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
    Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soft, chewable gelatin-based pharmaceutical oral formulations: a technical approach.
    Dille MJ; Hattrem MN; Draget KI
    Pharm Dev Technol; 2018 Jun; 23(5):504-511. PubMed ID: 28532266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation.
    Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L
    Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-amylose sodium carboxymethyl starch matrices for oral, sustained drug-release: formulation aspects and in vitro drug-release evaluation.
    Brouillet F; Bataille B; Cartilier L
    Int J Pharm; 2008 May; 356(1-2):52-60. PubMed ID: 18280069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the pharmacokinetics of miconazole after administration via a bioadhesive slow release tablet and an oral gel to healthy male and female subjects.
    Cardot JM; Chaumont C; Dubray C; Costantini D; Aiache JM
    Br J Clin Pharmacol; 2004 Oct; 58(4):345-51. PubMed ID: 15373926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Organoleptic properties of a new sweetening agent formulation based on aspartame and xylitol].
    Dumas P; Sauvageot F
    Ann Nutr Aliment; 1980; 34(1):121-30. PubMed ID: 7416659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of sodium salts on binary mixtures of bitter-tasting compounds.
    Keast RS; Canty TM; Breslin PA
    Chem Senses; 2004 Jun; 29(5):431-9. PubMed ID: 15201210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of ascorbic acid and sodium ascorbate in powder blends for tableting and in vitamin C chewable tablets by NIR-chemometry.
    Tomuţă I; Dudaş D; Vonica AL; Leucuţa SE
    Acta Pharm; 2013 Sep; 63(3):373-84. PubMed ID: 24152897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xanthan and galactomannan (from M. scabrella) matrix tablets for oral controlled delivery of theophylline.
    Vendruscolo CW; Andreazza IF; Ganter JL; Ferrero C; Bresolin TM
    Int J Pharm; 2005 May; 296(1-2):1-11. PubMed ID: 15885450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation of a extended release tablet containing dexibuprofen.
    Yi HG; Chi MH; Kim YI; Woo JS; Park ES
    Arch Pharm Res; 2008 Dec; 31(12):1637-43. PubMed ID: 19099235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo evaluation of a fast-disintegrating lyophilized dry emulsion tablet containing griseofulvin.
    Ahmed IS; Aboul-Einien MH
    Eur J Pharm Sci; 2007 Sep; 32(1):58-68. PubMed ID: 17628451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative bioavailability of griseofulvin lyophilized dry emulsion tablet vs. immediate release tablet: a single-dose, randomized, open-label, six-period, crossover study in healthy adult volunteers in the fasted and fed states.
    Ahmed IS; Aboul-Einien MH; Mohamed OH; Farid SF
    Eur J Pharm Sci; 2008 Oct; 35(3):219-25. PubMed ID: 18675344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properties of Delonix regia seed gum as a novel tablet binder.
    Adetogun GE; Alebiowu G
    Acta Pol Pharm; 2009; 66(4):433-8. PubMed ID: 19702177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chewability testing in the development of a chewable tablet for hyperphosphatemia.
    Lanz M; Baldischweiler J; Kriwet B; Schill J; Stafford J; Imanidis G
    Drug Dev Ind Pharm; 2014 Dec; 40(12):1623-31. PubMed ID: 24010939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The pharmacokinetics and bioequivalence of acipimox sustained-release tablets after a single and multiple oral administration in healthy dogs].
    Yang XG; Nie SF; Bai HJ; Zhang GJ; Pan WS
    Yao Xue Xue Bao; 2005 May; 40(5):457-61. PubMed ID: 16220793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
    Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.